Simple polyglutamine (polyQ) peptides aggregate in vitro via a nucleated growth pathway directly yielding amyloid-like aggregates. We show here that the 17-amino-acid flanking sequence (HTT NT ) N-terminal to the polyQ in the toxic huntingtin exon 1 fragment imparts onto this peptide a complex alternative aggregation mechanism. In isolation, the HTT NT peptide is a compact coil that resists aggregation. When polyQ is fused to this sequence, it induces in HTT NT , in a repeat-length dependent fashion, a more extended conformation that greatly enhances its aggregation into globular oligomers with HTT NT cores and exposed polyQ. In a second step, a new, amyloid-like aggregate is formed with a core composed of both HTT NT and polyQ.
There are nine known expanded CAG repeat diseases, in which expansion of a disease protein's polyQ sequence beyond a threshold repeat length causes progressive neurodegeneration through a predominantly gain-of-function mechanism 1 . In Huntington's disease, the repeat-length threshold is about 37 glutamines 2 . A major challenge to understanding disease mechanisms has been to discover physical properties of polyQ proteins that show repeat-length dependence in this threshold regime and that therefore might serve as a link in the progression from genetics to disease. PolyQcontaining aggregates are ubiquitously observed in these diseases 1 , and aggregation rates of polyQ sequences increase as repeat length increases 3 , mirroring correlations between the repeat length and the risk of disease and age of onset 1 . These observations led to the hypothesis that repeat length-dependent aggregation of polyQ is the triggering event in the mechanism of expanded CAG repeat diseases.
Not all data support this hypothesis, however. In particular, in cell and animal models, disease progression is not always correlated with aggregate burden, as measured by inclusions revealed by light microscopy 4 . There are also inconsistent reports of the nature of polyQ aggregates. Thus, whereas simple polyQ peptides follow a nucleated growth polymerization mechanism with direct formation of amyloidlike aggregates 3, [5] [6] [7] [8] , aggregation products of the polyQ-containing disease protein huntingtin (HTT) exon 1 include, in addition to amyloid fibrils 9 , oligomeric and protofibrillar structures 10,11 that many feel are more relevant to disease pathology 12 .
Although the human huntingtin (HTT) gene encodes a protein of more than 3,500 amino acids, expression of the first exon of the gene in cell and animal models is sufficient to replicate much of the pathology of Huntington's disease 1 , and there is growing evidence that proteolytic release of a fragment containing exon 1 is required for toxicity 13 . The amino acid sequence of the translation product of human HTT exon 1, which includes the polyQ sequence, is shown in Table 1 . As polyQ repeats are the only apparent common feature of the nine expanded polyQ repeat disease proteins 1 , we have extensively studied a series of simple polyQ peptides that contain flanking lysine residues added for solubility [5] [6] [7] [8] 14 . We found that these peptides aggregate via a nucleated growth polymerization mechanism in which the critical nucleus is a rarely populated form of the monomer [5] [6] [7] [8] . In these peptides, increases in aggregation rates for peptides with longer polyQ repeat lengths are associated with more favorable equilibrium constants for nucleus formation 5 . We also showed previously that the proline-rich flanking sequence (oligoPro) on the Cterminal side of the polyQ in exon 1 reduces aggregation kinetics and aggregate stability but does not fundamentally change the aggregation mechanism 14 . Its effect is also directional; oligoPro added to the N terminus of polyQ has no impact on aggregation 14 .
Intrigued by these oligoPro effects, we turned our attention to the 17-amino-acid sequence at the N terminus of the HTT protein, just upstream from the polyQ segment. In this paper, we describe detailed analysis of the in vitro aggregation mechanism of chemically synthesized peptide models for human HTT exon 1 that include this 17-amino-acid sequence (HTT NT ). We show that addition of HTT NT to polyQ causes marked changes in the aggregation mechanism, intermediates and products. We also show that this behavior is grounded in a kind of reciprocal cross-talk between the polyQ and HTT NT segments, both of which are intrinsically unfolded protein sequences 15 . This work reveals a complex pathway featuring various aggregate structures and suggests an unanticipated degree of conformational communication between adjacent disordered elements in intrinsically unfolded protein sequences. These data are consistent with previous reports showing modulation of polyQ aggregation by flanking sequences in general [16] [17] [18] [19] [20] [21] and the HTT N terminus in particular 22, 23 .
RESULTS
The role of the HTT N terminus in exon 1 aggregation To explore possible effects of the HTT exon 1 N-terminal 17 amino acids on polyQ aggregation, we generated the peptide HTT NT Q 35 ( Table 1) , subjected it to a disaggregation procedure required to ensure the absence of pre-existing aggregates 24 and studied its aggregation in PBS buffer at 37 1C. We found that 3 mM HTT NT Q 35 undergoes aggregation significantly (P o 0.001 at t ¼ 10.5 h) more rapidly than 3 mM Q 35 (Fig. 1a ). In addition, the peptide HTT NT Q 36 P 10 aggregates somewhat less rapidly than HTT NT Q 35 but much more rapidly than Q 35 (Fig. 1a) ; this shows that, although the aggregation-suppressing ability of oligoPro also operates within the exon 1 context, the enhancing effect of HTT NT is dominant over the suppressing effect of oligoPro. As discussed above, when oligoPro was placed C-terminal to polyQ, the aggregation rate was diminished compared with that of the polyQ sequence alone (compare 25 mM Q 35 P 10 with 25 mM Q 35 in Figure 1a ), but oligoPro placed N-terminal to polyQ had no effect 14 (data not shown). In contrast, the HTT NT effect did not seem to depend on where the HTT NT was placed. Thus, Q 35 HTT NT shows an aggregation rate that is much faster than that of Q 35 and not significantly (P 4 0.01 at t ¼ 0.75 h) different to that of HTT NT Q 35 (Fig. 1a) .
Despite the apparent dominant effect by the HTT NT sequence, the kinetics of a series of HTT NT Q N peptides continued to show a strong polyQ repeat-length dependence, as shown previously for both simple polyQ peptides 25 and for recombinantly produced exon 1 peptides 9 . Thus, whereas HTT NT , HTT NT Q 3 and HTT NT Q 15 all aggregated sluggishly, HTT NT Q 25 aggregated over a period of 1-2 d and, as discussed above, HTT NT Q 35 aggregated within a few hours ( Fig. 1b) . Although some of the peptides examined in Figure 1b contain a F17W mutation to allow certain fluorescence experiments (described below), this mutation did not appreciably affect aggregation properties. Control experiments in an Table 1 Amino acid sequences of exon 1-related peptides
Name or identifier Sequence
Human HTT exon 1 
FRET-HTT NT Q 3
¥ATLEKLMKA FESLKSW---QQQ
HTT NT Q 20 P 10 (F11A F17A)
HTT NT Q 20 P 10 (M1X M8X)
HTT NT Q 20 P 10 (F17W)
HTT NT Q 20 P 10 (F11W) HTT NT Q 20 P 10 background show that replacement of either Phe11 or Phe17 with tryptophan in the HTT NT segment yields aggregation kinetics similar to those of the corresponding wild-type peptide ( Fig. 1c) .
Previously, we found that early stages of the aggregation of simple polyQ peptides show a modest concentration dependence consistent with a nucleated growth polymerization mechanism and a critical nucleus of one 5 , as shown for Q 30 in Figure 1d . In contrast, the initial stages of aggregation of the exon 1-related sequence HTT NT Q 30 P 6 (previously, we found no appreciable difference between a Pro 6 and a Pro 10 sequence 14 ) yields a log-log plot of initial kinetics versus concentration 5 (Fig. 1d ) with a slope of approximately 1, corresponding to a calculated critical nucleus (n*) of about À1. The n* ¼ À1 value indicates a rate/concentration relationship for the early aggregation kinetics of HTT NT Q 30 P 6 that is consistent with a nonnucleated, 'downhill' aggregation mechanism 26 for oligomer formation, without a kinetic barrier to spontaneous aggregation. This analysis suggests that polyQ peptides containing the HTT NT sequence spontaneously aggregate by an entirely different mechanism than that of simple polyQ peptides, a conclusion that is further supported by additional data presented below.
Previously, we found that when simple polyQ monomers undergo spontaneous aggregation in aqueous solution, the earliest observable aggregates have fibril-associated properties similar to those of the final product 5 . In contrast, when the HTT NT Q 30 P 6 peptide aggregates, electron micrographs showed that the initial products were oligomeric and protofibrillar ( Fig. 2) . Later in the time course, various other aggregated structures appeared that were more fibril-like ( Fig. 2) . A relationship between the formation of such oligomeric products and non-nucleated, downhill aggregation kinetics ( Fig. 1d ) fitting a classical colloidal coagulation model has been suggested previously for other protein-aggregation reactions 27, 28 . d Figure 1 Aggregation kinetics of huntingtin exon 1 mimic peptides exploring various polyQ repeat lengths. (a) Basic HTT NT effect. HPLC sedimentation assay following aggregation of HTT NT (5 mM,
Role of polyQ repeat length on 5 mM peptides. HPLC sedimentation assay following aggregation of HTT NT 
(c) Role of HTT NT mutations in a HTT NT Q 20 P 10 peptides ( Table 1 ) incubated at B6 mM: wild-type HTT NT sequence sometimes discourages aggregation 29 , HTT NT might enhance exon 1 aggregation compared to our simple polyQ peptides because it replaces the Lys-Lys pair at the N terminus of the model polyQ peptides (see introduction and Table 1 ). However, the aggregation kinetics of 3 mM HTT NT K 2 Q 35 , an exon 1 analog containing a Lys-Lys pair inserted between HTT NT and Q 35 , were not significantly (P 4 0.01 at t ¼ 0.3 h) different from the kinetics of 3 mM HTT NT Q 35 but at the same time were significantly (P o 0.001 at t ¼ 10.5 h) faster than the kinetics of 3 mM Q 35 (Fig. 1a ). In addition, mutations that reduce the hydrophobic character of HTT NT without altering charged residues abrogated the rapid aggregation kinetics in an exon 1 peptide ( Fig. 1c) , confirming that the HTT NT segment provides some positive, sequencespecific contribution to aggregation rather than simply replacing a Lys-Lys aggregation suppressor. (ii) An obvious alternative possibility is that HTT NT itself might be highly aggregation prone. Unexpectedly, however, we found that a peptide consisting solely of the HTT NT sequence aggregated sluggishly under our standard conditions ( Fig. 1a,b ). (iii) Another possible explanation is that the combination of all or part of HTT NT with the first portion of the polyQ sequence might create a new aggregation sequence motif with much more robust aggregation kinetics than either polyQ or HTT NT alone. However, HTT NT peptides containing short to intermediate lengths of polyQ also aggregated slowly (Fig. 1b) , and robust aggregation kinetics ensued for longer polyQ constructs even when HTT NT was attached to the polyQ C terminus ( Fig. 1a ), which creates an entirely different sequence at the Q n -HTT NT junction; these data suggest that polyQ abutted to HTT NT does not simply create a powerful, novel, linear aggregation motif. The HTT NT K 2 Q 35 data ( Fig. 1a ) also argues against a novel aggregation motif because, if there were such a motif at the junction of the HTT NT and polyQ sequences, the highly charged Lys-Lys insertion would be expected to disrupt it. (iv) It is also possible that the HTT NT sequence might normally exist as a well-behaved oligomeric species, such as a dimer or trimer, that can accelerate aggregation by concentrating and/ or orientating the polyQ elements. However, size-exclusion chromatography (SEC) mobility showed that the HTT NT peptide migrates as a monomer (Fig. 3) , and SEC elution profiles (data not shown) showed no evidence of higher assembly states. Likewise, CD spectra of HTT NT did not change with respect to concentration ( Fig. 4a) , consistent with a non-associating system. (v) Another possibility is that, in analogy to a recent report of the ability of expanded polyQ to destabilize a folded protein domain 20 , the HTT NT segment may exist in a folded and/or compact state that resists aggregation but unfolds or extends when attached to expanded polyQ, enhancing its aggregation; disruption of the folded state is a common trigger for globular protein aggregation 30 . We explored this last hypothesis in detail, as described below.
Arguing against this postulated polyQ-induced unfolding mechanism for the HTT NT effect is the fact that most peptides the size of HTT NT do not fold into stable, globular structures but, rather, are disordered. Notably, however, analytical SEC suggests that the HTT NT sequence is actually relatively compact in solution. A series of simple polyQ peptides yielded migration rates in SEC that fit a straight line In the presence of this relatively low TFE concentration, the HTT NT adopts an a-helical structure, as evidenced by the negative bands at 208 nm and 222 nm. The development of structure is protein-concentration dependent, suggesting an oligomeric state under these conditions. ( Fig. 3a) . As expected, peptides that are predicted to be extended and thus have larger hydrodynamic radii, such as an alanine-rich peptide strongly favoring an a-helical structure 31 and a Pro 14 peptide favoring polyproline type II helix 32 , migrated faster than polyQ peptides of equivalent length. Insulin and aprotinin, which show smaller hydrodynamic radii caused by their compact structures, migrated-as expected-more slowly than the polyQ peptides of equivalent length. Within this data set, the HTT NT peptide also migrated substantially more slowly than expected for a peptide of its molecular weight, suggesting that-like insulin and aprotinin-HTT NT has a relatively small hydrodynamic radius.
To confirm the compactness of the HTT NT peptide, we conducted a fluorescence-based resonance energy transfer (FRET) experiment in which we replaced Met1 of HTT NT with the resonance energy acceptor nitrotyrosine, and Phe17 with the resonance energy donor tryptophan 33 in the context of an HTT NT Q 3 sequence ('FRET-HTT NT Q 3 '). Compared with HTT NT Q 3 containing only the F17W replacement, the tryptophan fluorescence of the FRET-HTT NT Q 3 peptide decreased by about 50% (data not shown), corresponding to a calculated average separation between donor and acceptor groups of 24 ± 0.5 Å (Fig. 3b ). This is substantially shorter than the average end-to-end distance of 34.5 ± 4 Å calculated 34 for a 17-residue peptide in an extended statistical coil conformation. This theoretical value is supported by a FRET analysis of the HTT NT Q 3 peptide in 6 M urea, which yielded a separation of 33.9 ± 0.5 Å (Fig. 3b) . Thus, in agreement with the SEC data, HTT NT in the HTT NT Q 3 context in native buffer seems to be markedly collapsed.
Given this evidence for a collapsed structure in an isolated HTT NT peptide, we investigated whether it was possible for expanded polyQ sequences to disrupt that collapsed state in peptides dissolved in PBS. We found that for the FRET-exon 1 mimic peptide containing a Q 20 repeat, the average separation between nitrotyrosine and tryptophan in the HTT NT sequence did not significantly change (P 4 0.01).
However, the corresponding separation for the Q 37 repeat peptide expanded to 32 ± 1 Å (P o 0.01), a value approaching the 34-Å range obtained both by measurement of HTT NT Q 3 in urea and by calculation based on an assumed statistical coil configuration (Fig. 3b) . The data are thus consistent with a mechanism in which the HTT NT segment of exon 1 is normally in a collapsed state that is resistant to aggregation but that, when connected to an expanded polyQ sequence, becomes extended and labile to aggregation-an effect analogous to what has previously been observed for a globular protein 20 .
HTT NT has no stable secondary structure Although several features of the above results are consistent with HTT NT (in the absence of a connected expanded polyQ) being a compact domain, the short length of HTT NT makes it unlikely (but not impossible) that it possesses a unique, folded structure. To probe the secondary and tertiary structure of HTT NT , we applied two solution methods. The first, CD spectral analysis, proved equivocal. The CD spectrum of HTT NT at 35 1C (Fig. 4a) and the difference spectrum resulting from subtraction of a 35 1C spectrum from a 5 1C spectrum (data not shown) lack strong secondary-structure features, suggesting the absence of a stable structure. At the same time, deconvolution analysis of the 35 1C spectrum predicts substantial a-helical structure ( Fig. 4, see legend) , consistent with projections based on amino acid sequence 23, 35 . This interpretation of the CD spectrum is problematic, however, because the protein data sets used in programs such as ContinLL are thought to be unsuitable for deconvoluting CD spectra of short peptides 36 . Figure 6 PONDR analysis of the first 600 amino acids of the human huntingtin sequence. Segments with low PONDR scores are predicted to be stably folded and high scores (near 1) disordered. Short segments spiking below a PONDR score of 0.5 are predicted to be MoRFs (see text). Calculated using the VX-LT version of PONDR. Access to PONDR was provided by Molecular Kinetics (http://www.pondr.com/). 
Ala10 Glu12 Lys15 The CD dichotomy was clarified by high-resolution NMR analysis ( Fig. 5) , which strongly suggests the absence of stably folded structure. Two-dimensional proton TOCSY and NOESY NMR analyses show that HTT NT adopts predominantly unfolded, random-coil conformations characterized by small spectral dispersion, small secondary chemical shifts and strong sequential H a (i) À H N (i + 1) NOEs with few sequential H N (i) À H N (i + 1) or medium-range NOEs. A single, weak, medium-range NOE cross-peak connects the Thr3 H a and Glu5 HN protons (Fig. 5b) . The region around these residues shows the largest negative H a secondary chemical shifts and the most H N (i) À H N (i + 1) NOE cross-peaks ( Fig. 5a) , indicating transient existence of a few residues in the a-helix quadrant of F,C space. Despite this slight propensity, there is clearly no stable a-helix in this peptide in solution under physiological conditions.
Thus, in the absence of an expanded polyQ, HTT NT adopts a conformation that lacks appreciable secondary and tertiary structural features but at the same time exists in a collapsed state. Results from the sequence-analysis algorithm PONDR (Molecular Kinetics; http:// www.pondr.com/) are consistent with this, predicting the HTT NT sequence to be a molecular recognition feature (MoRF) 37 capable of engaging in coupled folding and binding interactions 15 (Fig. 6) . Such sequences tend to be collapsed coils in native buffer 15 , often taking up a-helical conformations when complexed with their binding partners. Consistent with this, HTT NT has essentially no a-helical structure in isolation (see above) but takes on a substantial amount of a-helical structure in the presence of low concentrations of trifluoroethanol, as revealed by CD (Fig. 4b) .
A multistep aggregation mechanism When the assembly of simple polyQ peptides into amyloid-like aggregates is monitored by multiple analytical techniques, the data from all measures track closely, suggesting the absence of reaction intermediates 5 . In contrast, HTT NT -containing exon 1 peptides show different aggregation curves depending on the analytical method ( Figs. 7 and 8) . In particular, thioflavin T (ThT) binding (D), commonly used for measuring the presence of amyloid-like structure 38 , generated reaction curves that were delayed compared to the curves from the HPLC sedimentation (~) and light-scattering (J) assays ( Fig. 7b and 8c) . Thus, for the HTT NT Q 30 P 6 peptide ( Fig. 7 ) at 6.25 h, the difference between the ThT value (D) and the HPLC value (~) is statistically significant (P o 0.01); at later time points (19 h, 120 h) the difference is insignificant (P 4 0.01). The observation of the ThT lag followed by a burst suggests that the initial aggregates are not amyloid-like, whereas later aggregates are. FTIR analysis also suggests that the initial aggregation product is qualitatively different-showing more coil and less b-structure-compared to aggregates isolated later in the time course (Fig. 8e) . This is also consistent with the EM data (Fig. 2) . Details of the structures of these intermediates are revealed by further analysis of HTT NT Q 30 P 6 ( Fig. 7) and HTT NT Q 20 P 10 (Fig. 8) aggregates isolated from ongoing reactions. In particular, dot blot analysis of these aggregates showed that polyQ in the initial aggregates is readily accessible to an antibody against a linear polyQ epitope but is masked in the later aggregates ( Figs. 7c and 8d) . In addition, the initially formed aggregates are poor templates for recruiting polyQcontaining peptides, whereas the later, fibrillar aggregates are capable of seeding polyQ elongation (Fig. 8b) . Seeding activity is a feature particularly associated with amyloid-like aggregates 39 . Furthermore, whereas a tryptophan residue inserted in place of phenylalanine at position 11 or 17 was solvent exposed both in the monomeric peptide and in the initial aggregates, it became less solvent accessible (based on its fluorescence maximum) as the aggregation reaction proceeded, with a time course that parallels the disappearance of polyQ antibody binding epitopes (Figs. 7a ('); 8B (,m)). In contrast, when the isolated HTT NT peptide itself aggregated slowly, the tryptophan residue of the F17W mutant remained fully solvent exposed in the aggregate fraction, even after 800 h (Fig. 7a (D) ); this is consistent with the apparently inability of aggregates of HTT NT lacking a long polyQ track to progress beyond the oligomer stage, in agreement with EM analysis (Fig. 2l) . Although the initial aggregates of HTT NT Q N peptides seem to be less tightly packed than the later aggregates, they are sufficiently structured that they are protected from proteolyis by trypsin, in contrast to soluble, monomeric HTT NT (Fig. 8a) .
Thus, the initial aggregates in this HTT NT -mediated mechanism are nonfibrillar oligomers, with their HTT NT segments composing the core but their polyQ segments remaining unstructured and available for antibody binding. Subsequently, the polyQ elements also become integrated into the aggregate core structure, which takes on a more fibrillar character both in the polyQ and HTT NT elements. Growth into larger fibrillar assemblies, as seen in EM, take place at later incubation times. FTIR analysis (Fig. 8e) showed that the initial aggregates (before burial of Trp17) contain a substantial amount of coil and turn conformations in addition to b-structure. Notably, FTIR spectra of all aggregates isolated after Trp17 burial feature a single b-sheet band at B1,626 cm À1 and are indistinguishable from each other and from aggregates of simple polyQ (Fig. 8e) .
Notably, at a time when the major changes in aggregate structure were occurring, as evidenced by ThT binding, tryptophan fluorescence shift, FTIR, EM and polyQ antibody binding, the vast bulk of the exon 1 peptide (480%) did not pellet after centrifugation ( Figs. 7 and 8) and migrated as a single, monomeric (Fig. 3a) species in SEC (M.J. and R.W., unpublished data). Coincident with the timing of the changes in aggregate structure, there was a marked increase in the rate of monomer loss, suggesting that a nucleation event had occurred.
DISCUSSION
The results presented here are consistent with the model shown in Figure 9 . In this model, the HTT NT peptide has an intrinsic tendency to collapse into an aggregation-resistant compact coil state, but an attached, expanded polyQ sequence induces in this segment a more extended state. When the HTT NT sequence is extended, it becomes susceptible to formation of a metastable, micelle-like aggregate, with the HTT NT segment making up the loosely packed core and the flanking polyQ sequence excluded from the core. Although this initial aggregation reaction is non-nucleated, amyloid nuclei seem to rise stochastically from among these initial, prefibrillar aggregates. With the emergence of amyloid fibril structure, the remaining monomeric fraction-which represents the vast majority of the exon 1 molecules at the time when these postulated nucleation events are taking placefuels the ongoing fibril-elongation reaction. Although many details of this proposed mechanism remain to be worked out, it seems that longer polyQ sequences favor aggregation in two ways: first, by disrupting the HTT NT compact coil and thereby facilitating initial HTT NT aggregation; and, second, by improving the efficiency of the nucleation events proposed to occur within the prefibrillar aggregate population.
In many respects, the mechanism shown in Figure 9 resembles the 'conformational conversion' model for spontaneous amyloid growth proposed for yeast prion amyloid formation 40 . In that model, relatively loosely structured spherical oligomers form first, then convert into a more structured oligomer that can grow by recruiting other oligomers or monomers. In Figure 9 , we envision that the nucleation process for exon 1 aggregation consists of the stochastic rearrangement of some oligomers or protofibrils into amyloid-like structures capable of rapidly propagating via monomer addition. That is, although some prefibrillar aggregates readily dissociate back to monomers (M.J. and R.W., unpublished data), those aggregates that successfully undergo the nucleation process seem to be required intermediates, under these experimental conditions and, therefore, to be on-pathway 41 to amyloid formation. The kinetics of the only known alternative route to amyloid formation-the previously described 5 nucleated growth mechanism-are too slow to provide the observed rapid fibril formation (A.K.T. and R.W., unpublished data). Providing further support for the scheme shown in Figure 9 , and extracting details on the mechanism and kinetics of nucleation process and other assembly steps are the focus of current work.
Amino acid sequence has been viewed as having two major roles in influencing protein aggregation and amyloid formation 30 . First, globular proteins become more amyloidogenic when their folded Figure 9 Mechanism of HTT NT -mediated exon 1 aggregation. The HTT NT domain (green) unfolds in a polyQ repeat length-dependent fashion and, once unfolded, self-aggregates without a nucleation barrier to form oligomers with cores comprising HTT NT and not polyQ (red). The next identified aggregates involve both HTT NT and polyQ in amyloid-like structure; oligoPro (black) is not incorporated into the core. This drawing is schematic and is not meant to imply any details of aggregate structure, except that final aggregates are rich in b-sheet, are fibrillar and involve both HTT NT and polyQ. Although the initial formation of oligomers shows non-nucleated, downhill kinetics, it is likely that a nucleation event takes place stochastically within the prefibrillar aggregate population, as shown in brackets, to trigger rapid amyloid growth.
structures are destabilized, for example, by point mutations. Second, amyloidogenic proteins possess specific primary-sequence elements that constitute the core regions of the amyloid structure, and mutations within these regions can abrogate or enhance amyloid formation. Our studies on HTT exon 1 aggregation, however, reveal other means by which sequence can influence aggregation rate. Recently, we reported that an oligoPro sequence on the C-terminal side of a polyQ tends to decrease aggregation rate and aggregate stability, apparently by favoring more aggregation-resistant conformations 14 .
Here we show that adjacent elements of intrinsically unfolded polypeptides can engage in an 'aggregation two-step' in which one element supplies rapid initial aggregation kinetics (but is insufficient to form amyloid or provide stability) whereas a second, connected element (which in isolation aggregates relatively slowly) provides the means to a highly stable amyloid structure. In a further twist, we show that a degree of compactness in the unstructured HTT NT sequence provides protection against aggregation and that the previously described destabilizing ability of a connected polyQ 20, 42 disrupts this protective structure and opens the door to robust aggregation. Together, these results suggest that the rules by which primary sequences inform the direction and kinetics of protein aggregation may be much more complex than previously believed 29 .
Perhaps 25% of the proteome consists of sequences that do not exist as ordered globular or fibrous structures but rather are intrinsically unfolded 43 . The results in this paper, together with our previous studies on the proline-rich sequence of HTT exon 1 14 , illustrate the dramatic effects on peptide conformation and aggregation imparted through subtle sequence effects within a single disordered polypeptide. In particular, the ability of disordered polyQ sequences to influence the folding stability of adjacent domains 20, 42 is an unprecedented phenomenon in protein science whose limits, and still obscure mechanism, are yet to be elucidated. What is particularly unexpected about our data on the effect of expanded polyQ on HTT NT is the implied ability of the compact coil state of HTT NT to resist aggregation; classically, compact but disordered 'molten globule' states of globular proteins have been considered to be aggregation-prone 44 . PolyQ destabilization of adjacent domains may account for the observation that longer polyQ tracts are often associated with reductions in protein activity 7 , a trend suggesting the possibility that some loss of function 45 might accompany the toxic gain of function that is generally thought to dominate polyQ diseases 1 .
We believe HTT NT derives its unusual impact on aggregation mechanism and rate because of its resemblance to MoRF sequences 37 , which exist as condensed coils poised at the cusp of foldedness, designed by nature for coupled folding and binding processes in the cell 15 . Although this designation for HTT NT is based solely on PONDR analysis (Fig. 6) , the biophysical properties of HTT NT are entirely consistent with this notion, and HTT is well known to possess many interaction partners 46 .
Our results add to a growing literature on interactions between polyQ and its flanking sequences in aggregation reactions. After initial reports on the ability of flanking sequences to modulate aggregation of polyQ disease proteins in cells 47 , several papers [16] [17] [18] [19] 21 appeared describing aggregation by a flanking sequence that facilitates aggregation of the polyQ portion, sometimes as a clearly defined initial step 19, 21 and sometimes initiated by the destabilizing influence of an adjacent expanded polyQ 20 .
Our results put into a molecular biophysics context several recent cell-based studies of the role of the HTT NT sequence in exon 1 aggregation and toxicity. Using models in which exon 1 fragments are expressed in mammalian or yeast cells, several groups have shown that the presence or absence of HTT NT , as well as mutations within or adjacent to HTT NT , introduce complex alterations in subcellular localization, aggregate formation and/or cytotoxicity or growth retardation 22, 23, 35, 48 . Studies showing that binding of HTT NT by a specific immunoglobulin fragment inhibits exon 1 aggregation and toxicity in several cell models 49 are consistent with our data showing that HTT NT aggregation is the first step in exon 1 aggregation and that this depends on destabilization of a compact state in HTT NT . Despite its lack of a-helical structure, the ability of HTT NT to form a-helix structure in response to its environment (Fig. 4b) is consistent both with suggestions that HTT NT may mediate exon 1 targeting to membrane fractions 23, 35 and with our hypothesis that HTT NT is a MoRF sequence that mediates coupled folding and binding to protein targets. The ability of HTT NT to markedly alter the polyQ aggregation mechanism and the ability of HTT NT mutations (Fig. 1c) and binding factors 49 to abrogate or modulate this effect are likely to contribute to some observed cellular effects. In fact, our recognition that polyQ sequences may aggregate by entirely different mechanisms, depending on flanking sequences, suggests that at least some of the diversity of aggregate morphologies observed in exon 1 cell and animal models 11, 50 may ultimately be explained by the biophysical character of the exon 1 sequence itself.
METHODS

Materials.
We obtained all HTT-related peptides, as well the Pro14 and alanine-rich peptide 'Bal' 31 in nonpurified form from the small-scale custom peptide synthesis facility of the Keck Biotechnology Center at Yale University (http://keck.med.yale.edu/ssps/). We purified peptides by reverse-phase HPLC and confirmed structures by MS on an Agilent 1100 electrospray MSD 24 . Purified peptides were routinely freshly disaggregated before use, as described 24 . Porcine insulin and aprotinin were from Sigma-Aldrich. Acetonitrile, hexafluoroisopropanol (99.5% (v/v), spectrophotometric grade) and formic acid were from Acros Organics, trifluoroacetic acid (99.5% (v/v), Sequanal Grade) was from Pierce and trifluoroethanol was from Sigma-Aldrich.
General methods. The sedimentation assay 24 , the ThT and 901 light-scattering assays 51 and the nucleation kinetics analysis 5, 24 have been described. We isolated aggregates for analysis by centrifuging a reaction aliquot at 20,817g in an Eppendorf centrifuge at 4 1C for 30 min, washing the pellet two or three times with PBS, resuspending it in buffer and determining the aggregate concentration by an HPLC analysis of a dissolved aliquot, as described 24 .
Electron microscopy. We took aliquots of the ongoing aggregation reaction mixture at different time points for EM visualization. We placed 3 ml of sample on a freshly glow-discharged carbon-coated grid, adsorbed for 2 min, and then washed the grid with deionized water before staining the protein with 2 ml of 1% (w/v) uranyl acetate and blotting. Grids were imaged on a Tecnai T12 microscope (FEI) operating at 120 kV and 30,000Â magnification and equipped with an UltraScan 1000 CCD camera (Gatan) with post-column magnification of 1.4Â.
Circular dichroism. We collected CD spectra using a Jasco J-810 spectrapolarimeter with a 1-mm pathlength quartz cuvette. HTT NT samples in 20 mM Tris-TFA, pH 7.2. The spectra were collected immediately after thawing (from À80 1C) the disaggregated peptide samples. Scans were made at 20 nm per min with steps of 0.5 nm and an averaging time of 8 s. The reported spectra are averages taken over four scans.
Proton nuclear magnetic resonance. The HTT NT sample for NMR experiments contained 40 mM peptide in 20 mM sodium phosphate buffer, pH 7.2, 0.02% (w/v) sodium azide, 6% 2 H 2 O. We carried out NMR experiments on a Bruker Avance 800 MHz NMR spectrometer, equipped with a 5-mm z-axis gradient cryoprobe. The water solvent peak was suppressed using the WATER-GATE W5 pulse sequence 52 . We acquired two dimensional homonuclear NOESY and TOCSY 53 data at 5 1C, using a 1.5-s recycle delay and mixing times of 200 ms and 60 ms. Complete backbone and side chain proton assignments of HTT NT were obtained. H a secondary chemical shifts (Dd H a ) were calculated by subtracting sequence-corrected random coil values 54 .
Analytical size-exclusion chromatography. We conducted SEC experiments with a Superdex peptide HR10/30 (Pharmacia Biotech) column on a Bio-Rad (Biologic Duo flow) chromatograph using a flow rate of 1 ml min À1 , detecting at 215 nm at ambient temperature (23 1C). Peptides were suspended in PBS (polyQ peptides and HTT NT after disaggregation) at 20-100 mM and 100 ml were injected. The K av values and the plot between K av versus logMW were calculated as described in the GE Healthcare handbook Gel Filtration: Principles and Methods available on the GE Healthcare web site (http://www.gelifesciences. com/protein-purification).
Fluorescence resonance energy transfer. FRET peptides ( Table 1) were purified and disaggregated. The peptide solution in TFA in water, pH 3.0, obtained after the ultracentrifugation step of the disaggregation procedure was immediately adjusted to 5 mM concentration in 10 mM PBS, pH 7.4, and its fluorescence was determined. Peptide solutions were confirmed to be aggregatefree at the end of the FRET measurements by EM, HPLC, ThT and 901 lightscattering measurements. Fluorescence spectra were recorded at room temperature (23 1C) with excitation and emission slit widths at 5 nm. Raw data obtained were buffer subtracted and energy transfer efficiencies (E) were calculated from fluorescence intensities at 353.5 nm from the emission spectra of the F17W and doubly labeled FRET peptide. The D-A distance (r) for each peptide was determined from the E value and the Ro value (26 Å ) for the nitrotyrosine/ tryptophan FRET pair 33, 55 . The measurements were carried out in triplicate and the mean value (r) is reported with s.d.
We determined peptide concentrations underpinning the FRET calculations in two different ways, obtaining similar results. In one method, we used amino acid composition analysis (Keck Biotechnology Center, Yale University) to calibrate a stock solution of the peptide which was then used as an HPLC standard for future determinations 24 . In the second method, we used the UV absorption peaks of tryptophan at 280 nm and of nitrotyrosine at 381 nm to normalize concentrations of F17W and doubly labeled FRET peptides using the extinction coefficients of tryptophan e 280 nm ¼ 5,600 M À1 cm À1 and nitrotyrosine e 381 nm ¼ 2,200 M À1 cm À1 , respectively 56 .
Dot blots. We carried out dot blots as described 21 . Aggregate samples were harvested, resuspended and quantified as described in 'General methods' , and aliquots containing 400 ng of aggregates were transferred to a nitrocellulose membrane. In parallel, a portion of the unfractionated aggregation reaction mixture was transferred to nitrocellulose membrane at various time intervals. Blots were incubated overnight with TBST buffer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% (v/v) Tween-20, 0.05% (w/v) sodium azide) containing 5% (w/v) BSA, washed three times with TBST and incubated with a 10 nM solution of purified MW1 antibody 57 (a gift from J. Ko and P. Patterson) for 2 h. After washing with TBST to remove unbound material, blots were incubated 2 h with a 1:15,000 dilution of a peroxidase conjugate of anti-mouse IgG (whole molecule) (Sigma, A4416) and then washed four times with TBST. Blots were visualized with enhanced chemiluminescence solution (Pierce #A4416) following the manufacturer's instructions.
Tryptophan fluorescence emission of aggregates. Aggregates were isolated at different times as described in 'General methods' , then resuspended in 300 ml 150 mM NaCl, 10 mM phosphate, pH 7.4, and analyzed on a Perkin Elmer luminescence LS50B spectrometer. The samples were excited at 280 nm and emission was scanned between 290 nm and 550 nm. The wavelength at the emission intensity maximum was recorded.
Fourier transform infrared spectroscopy. We carried out Fourier transform infrared spectroscopy of various samples using an MB series spectrophotometer with PROTA software (ABB Bomem). We harvested protein aggregates by centrifugation at 20,817g and washed the pellet three times with PBS. Spectra of resuspended aggregates were recorded at 4-cm À1 resolution (400 scans at room temperature). Spectra were corrected for the residual buffer absorption by subtracting the buffer-alone spectrum interactively until a flat baseline was obtained between 1,700-1,800 cm À1 . Second-derivative spectra for the Amide I region were calculated from the primary spectrum by using PROTA software.
For the Q 15 monomer sample, we purified the peptide by reverse-phase HPLC with an aqueous acetonitrile gradient in 5 mM HCl to avoid exposure of the peptide to TFA, which gives a large peak in FTIR. We pooled and lyophilized the peak fractions and dissolved the powder in 50 ml of 1 mM HCl, and then centrifuged the samples for 1 h at 435,680g. A 25-ml aliquot was carefully removed and mixed with 25 ml of a 2Â PBS buffer and centrifuged for 30 min at 435,680g, and the supernatant was subjected to analysis. This material seemed to contain about 20% by mass of amyloid-like polyQ aggregates, based on ThT analysis, presumably because of its high concentration (2.4 mM) and the abbreviated and modified disaggregation protocol necessitated by the demands of the experiment.
Trypsin sensitivity of aggregates. For the monomer control, HTT NT was disaggregated and dissolved in TFA in water, pH 3, then added to a solution of trypsin (SEQUENZ-Trypsin, Worthington Biochemical Corporation) in 100 mM Tris-HCl, pH 7.0, to yield a 1:10 ratio of trypsin to peptide in 50 mM Tris. This solution was incubated at room temperature and monitored by injection of aliquots onto a RP-HPLC-MS system (Agilent 1100), which indicated efficient cleavage after the HTT NT lysine residues (data not shown).
Aggregates were harvested and quantified as described in 'General methods' , then incubated with trypsin at 1:10 (w/w) (trypsin: peptide) in 50 mM Tris, pH 7.0, at room temperature. LC-MS of digest centrifugation supernatants yielded no material. All the material was found in pellet fractions and was undigested (data not shown).
Microplate elongation assay. The elongation of biotinylated Q 29 (B-Q 29 ) on HTT NT Q 20 P 10 aggregates harvested at different times was done as described 6 .
Data analysis. For all reaction profiles, data sets were fit in Sigma Plot to either three-parameter equations (exponential decay, exponential rise to maximum or sigmoidal) or linear regression. Reported R 2 values and s.d. are from the Sigma Plot fits. Many data sets were obtained in duplicate, and those that were not are representative of multiple experiments. The tight error bars for the HPLC sedimentation assay data obtained in duplicate ( Fig. 1a , all data sets but for HTT NT and HTT NT Q 36 P 10 ), along with the excellent curve fits throughout Figure 1 , give us confidence in the data sets where only single replicates were taken (Fig. 1b,c) . Duplicate data points in Figure 7 were derived from two experiments run at different times, and some points (0.6 h, 4 h: ThT, LS; 28 h, 69 h: HPLC, ThT, LS) are represented by only one replicate. The larger error bars for ThT and LS readings at the later time points are typical for late-stage amyloid formation reactions as fibrils grow larger. P-values were calculated using the two-tailed Student's t-test.
